Search

Under pressure to demonstrate economic returns on research spending, the UK’s research councils are going to make academics think commercial and to cosy up to industry.

In the lean years since the post-genomics bust, venture funding has been hard to come by for Europe’s biotech start-ups. Now they have polished up their business models, and valuations are low, attracting investors back in.

In a rare example of a university tec transfer deal attracting an upfront payment, French pharma company Ipsen paying €1.25 million for a treatment licence.

The UK government has given £1.1 million to Plasticell Ltd to fund the development of a system to automate stem cell research.

Scotland is investing £9.5 million of public money in the Swedish stem cell company Cellartis AB to fund an R&D and manufacturing facility in Dundee.

Global acceptance of biotech crops increased in 2006, with acreage reaching 102 million hectares in 22 countries, according to a new report.

France’s best-known engineering school, the École Polytechnique, is mapping out a major expansion drive for the next five years.

The French presidential election is unlike any previous one: this time, both right and left are hoisting research policy to the top of their agendas.

The UK's National Environment Research Council (NERC) has launched Oceans 2025, an ambitious GBP120 million five-year programme.

The Czech Republic has capped off a series of investments by US software companies with the news that Red Hat is to set up a development centre in Brno.